HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roberts, D. G. Articles by Larsson, S. Search for Related Content PubMed PubMed Citation Articles by Roberts, D. G. Articles by Larsson, S.

European Journal of Cardio-Thoracic Surgery, Vol 3, 292-296, Copyright © 1989 by European Association for Cardio-thoracic Surgery

ARTICLES

Long-term follow-up of operative treatment for pulmonary metastases

DG Roberts, V Lepore, G Cardillo, L Dernevik, H Berggren, A Belboul, N al-Khaja and S Larsson
Department of Thoracic and Cardiovascular Surgery, Sahlgren's Hospital, University of Gothenburg, Sweden.

From 1954 onwards, 132 patients underwent 165 resections for pulmonary metastases. No other forms of therapy were adopted. The operative mortality was 7.6% (10 patients). After a minimum follow-up of 5 years, the overall survival rate was 20%. The 10- and 15-year survival rates were 6% and 3%, respectively. The major cause of late death was recurrence or spread of the primary disease in 102 patients (83.6%) while 5 patients died of reasons not related to cancer. Fifteen patients (12.3%) are still alive, 13 of whom have no clinical cancer. The presence of symptoms, the disease-free interval of less than 1 year and the number of metastases showed a statistically significant detrimental influence on survival (P less than 0.001, P less than 0.05 and P less than 0.046, respectively). The best 5-year survivals of 42%, 24%, 23% and 23% were noted for metastases from malignancies in the body of the uterus, kidney, bone and colon, respectively. Longterm survival or clinical cure can be achieved with surgery alone by an aggressive approach in selected malignancies.

This article has been cited by other articles:

				O. Rena, E. Papalia, A. Oliaro, P. Filosso, E. Ruffini, G. Maggi, and C. Casadio Pulmonary metastases from epithelial tumours: late results of surgical treatment. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 217 - 222. [Abstract] [Full Text] [PDF]

				T. Nakagawa, T. Kamiyama, K. Nakanishi, H. Yokoo, H. Kamachi, M. Matsushita, and S. Todo Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1248 - 1254. [Abstract] [Full Text] [PDF]

				A. Monteiro, N. Arce, J. Bernardo, L. Eugenio, and M. J. Antunes Surgical resection of lung metastases from epithelial tumors Ann. Thorac. Surg., February 1, 2004; 77(2): 431 - 437. [Abstract] [Full Text] [PDF]

				A. Rolle, R. Koch, S. K. Alpard, and J. B. Zwischenberger Lobe-sparing resection of multiple pulmonary metastases with a new 1318-nm Nd:YAG laser--first 100 patients Ann. Thorac. Surg., September 1, 2002; 74(3): 865 - 869. [Abstract] [Full Text] [PDF]

				O. Rena, C. Casadio, F. Viano, R. Cristofori, E. Ruffini, P. L. Filosso, and G. Maggi Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 906 - 912. [Abstract] [Full Text] [PDF]

				F. Loehe, S. Kobinger, R. A. Hatz, T. Helmberger, U. Loehrs, and H. Fuerst Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Ann. Thorac. Surg., July 1, 2001; 72(1): 225 - 229. [Abstract] [Full Text] [PDF]